Guru Ownership Trend
Guru Analysis for ADMA Biologics, Inc. (ADMA)
ADMA Biologics, Inc. (ADMA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 8 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $77.74 M.
Top institutional holders include Steven Cohen and Terry Smith.
Institutional sentiment is currently Bullish. This is evidenced by a $30.22 M net inflow during the quarter.
Recent activity highlights Paul Tudor Jones who increased their stake by 790.6%. Conversely, Chuck Royce reduced exposure by 97.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for ADMA Biologics, Inc. (ADMA)
Major holders include Steven Cohen ($29.63 M), Terry Smith ($14.86 M), Stanley Druckenmiller ($13.93 M). According to the latest reported data, 8 tracked investment managers collectively hold approximately 9.47 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $30.22 M, with 5 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 1 fully exited ADMA. The total reported sell value was $17.64 M.
Yes, 0 managers opened new positions in ADMA, and 5 increased their existing holdings. The total reported buy value was $47.85 M.
